This circular genome is both more plentiful than its nuclear counterpart and more prone to mutation. Currently, it is difficult to predict the way in which mtDNA mutations will pass from mother to child due to the interplay between the mitochondrial and nuclear genomes.
It is clear, however, that these mutations are more pronounced in tissues that place high energy demands on mitochondria. In spite of this, mtDNA mutations are not entirely a bad thing. In fact, the variability introduced into mtDNA sequences by these mutations helps link family members to one another and has proven useful in reuniting missing children with their mothers, grandmothers, brothers, and sisters.
Much remains to be learned about mtDNA, however, and continued study of this fascinating genome will continue to expand our understanding of human disease and human history for years to come.
Ingman, M. Mitochondrial genome variation and the origin of modern humans. Nature , doi Man, P. The epidemiology of Leber hereditary optic neuropathy in the North East of England. American Journal of Human Genetics 72, Owens, K.
Genomic sequencing in the service of human rights. International Journal of Epidemiology 31, Polyak, K. Somatic mutations of the mitochondrial genome in human colorectal tumours. Nature Genetics 20, doi Prezant, T. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nature Genetics 4, Schubert, C. Profile: Mary-Claire King. Nature Medicine 9, doi Song, S.
DNA precursor asymmetries in mammalian tissue mitochondria and possible contribution to mutagenesis through reduced replication fidelity. Proceedings of the National Academy of Sciences , Taylor, R. Mitochondrial DNA mutations in human disease. Nature Reviews Genetics 6, doi Epigenetic Influences and Disease.
Birth Defects: Causes and Statistics. Birth Defects: Prevention and Treatment. Copy Number Variation and Genetic Disease. Genetic Causes of Adult-Onset Disorders. Somatic Mosaicism and Chromosomal Disorders. Trisomy 21 Causes Down Syndrome. Genetic Origins of Microbial Virulence. Genetics of the Influenza Virus. Pathogenicity: Microbial Virulence. Complex Diseases: Research and Applications. Gene Interaction and Disease.
Gene Mapping and Disease. Multifactorial Inheritance and Genetic Disease. Polygenic Inheritance and Gene Mapping. Genomic Imprinting and Patterns of Disease Inheritance. Chromosome Abnormalities and Cancer Cytogenetics. Genes, Smoking, and Lung Cancer. Genetic Regulation of Cancer. Gleevec: the Breakthrough in Cancer Treatment. Human Chromosome Translocations and Cancer.
Proto-oncogenes to Oncogenes to Cancer. Cytogenetic Methods in Diagnosing Genetic Disorders. Gene-Based Therapeutic Approaches. Personalized Medicine: Hope or Hype? Citation: Chial, H. Nature Education 1 1 Did you know that you have a second genome?
Small cellular organelles called mitochondria contain their own circular DNA. What happens to your cells when this DNA mutates? Aa Aa Aa. Mitochondrial Anatomy and Physiology. Mitochondrial vs. Nuclear DNA. Figure 2. Mitochondrial DNA Mutations. Table 1: Estimated mitochondrial dNTP concentrations in rat tissues. Figure Detail. Clinical Manifestations of Mitochondrial Mutations. Classic Mitochondrial Syndromes. Table 3. And it encodes different proteins that are specific for the mitochondrial.
Now, remember those pathways that are within the mitochondrion for producing energy. Some of the enzymes in those pathways, and some of the proteins that are needed to function in those pathways, are produced by the mitochondrial DNA. The mitochondrial DNA is critically important for many of the pathways that produce energy within the mitochondria.
And if there's a defect in some of those mitochondrial DNA bases, that is to say a mutation, you will have a mitochondrial disease, which will involve the inability to produce sufficient energy in things like the muscle and the brain, and the kidney. So this is very helpful sometimes in determining how a person has a certain disorder in the family. Some cases of cyclic vomiting syndrome, particularly those that begin in childhood, may be related to changes in mitochondrial DNA.
This disorder causes recurrent episodes of nausea, vomiting, and tiredness lethargy. Some of the genetic changes alter single DNA building blocks nucleotides , whereas others rearrange larger segments of mitochondrial DNA. These changes likely impair the ability of mitochondria to produce energy. Researchers speculate that the impaired mitochondria may affect certain cells of the autonomic nervous system, which is the part of the nervous system that controls involuntary body functions such as heart rate, blood pressure, and digestion.
However, it remains unclear how these changes could cause the recurrent episodes characteristic of cyclic vomiting syndrome.
Mutations in at least three mitochondrial genes can cause cytochrome c oxidase deficiency, which is a condition that can affect several parts of the body, including the muscles used for movement skeletal muscles , the heart, the brain, or the liver. The mitochondrial genes associated with cytochrome c oxidase deficiency provide instructions for making proteins that are part of a large enzyme group complex called cytochrome c oxidase also known as complex IV.
Cytochrome c oxidase is responsible for the last step in oxidative phosphorylation before the generation of ATP. The mtDNA mutations that cause this condition alter the proteins that make up cytochrome c oxidase. As a result, cytochrome c oxidase cannot function. A lack of functional cytochrome c oxidase disrupts oxidative phosphorylation, causing a decrease in ATP production. Researchers believe that impaired oxidative phosphorylation can lead to cell death in tissues that require large amounts of energy, such as the brain, muscles, and heart.
Cell death in these and other sensitive tissues likely contribute to the features of cytochrome c oxidase deficiency. The deletions range from 1, to 10, nucleotides, and the most common deletion is 4, nucleotides.
Kearns-Sayre syndrome primarily affects the eyes, causing weakness of the eye muscles ophthalmoplegia and breakdown of the light-sensing tissue at the back of the eye retinopathy. The mitochondrial DNA deletions result in the loss of genes that produce proteins required for oxidative phosphorylation, causing a decrease in cellular energy production.
Researchers have not determined how these deletions lead to the specific signs and symptoms of Kearns-Sayre syndrome, although the features of the condition are probably related to a lack of cellular energy. It has been suggested that eyes are commonly affected by mitochondrial defects because they are especially dependent on mitochondria for energy. These genes provide instructions for making proteins that are part of a large enzyme complex.
This enzyme, known as complex I, is necessary for oxidative phosphorylation. The mutations responsible for Leber hereditary optic neuropathy change single amino acids in these proteins, which may affect the generation of ATP within mitochondria.
However, it remains unclear why the effects of these mutations are often limited to the nerve that relays visual information from the eye to the brain the optic nerve. Additional genetic and environmental factors probably contribute to vision loss and the other medical problems associated with Leber hereditary optic neuropathy.
Mutations in one of several different mitochondrial genes can cause Leigh syndrome, which is a progressive brain disorder that usually appears in infancy or early childhood. Affected children may experience delayed development, muscle weakness, problems with movement, or difficulty breathing. Some of the genes associated with Leigh syndrome provide instructions for making proteins that are part of the large enzyme complexes necessary for oxidative phosphorylation.
For example, the most commonly mutated mitochondrial gene in Leigh syndrome, MT-ATP6 , provides instructions for a protein that makes up one part of complex V, an important enzyme in oxidative phosphorylation that generates ATP in the mitochondria.
The other genes provide instructions for making tRNA molecules, which are essential for protein production within mitochondria. Many of these proteins play an important role in oxidative phosphorylation. The mitochondrial gene mutations that cause Leigh syndrome impair oxidative phosphorylation.
Although the mechanism is unclear, it is thought that impaired oxidative phosphorylation can lead to cell death in sensitive tissues, which may cause the signs and symptoms of Leigh syndrome.
People with this condition have diabetes and sometimes hearing loss, particularly of high tones. In certain cells in the pancreas beta cells , mitochondria help monitor blood sugar levels. In response to high levels of sugar, mitochondria help trigger the release of a hormone called insulin, which controls blood sugar levels.
Researchers believe that the disruption of mitochondrial function lessens the mitochondria's ability to help trigger insulin release. In people with MIDD, diabetes results when the beta cells do not produce enough insulin to regulate blood sugar effectively. Researchers have not determined how mutations in these genes lead to hearing loss.
When caused by mutations in this gene, the condition is usually characterized by muscle weakness myopathy and pain, especially during exercise exercise intolerance. More severely affected individuals may have problems with other body systems, including the liver, kidneys, heart, and brain. This protein is one component of complex III, one of several complexes that carry out oxidative phosphorylation.
Most MT-CYB gene mutations involved in mitochondrial complex III deficiency change single amino acids in the cytochrome b protein or lead to an abnormally short protein.
These cytochrome b alterations impair the formation of complex III, severely reducing the complex's activity and oxidative phosphorylation. Damage to the skeletal muscles or other tissues and organs caused by the lack of cellular energy leads to the features of mitochondrial complex III deficiency. Some of these genes provide instructions for making proteins that are part of a large enzyme complex, called complex I, that is necessary for oxidative phosphorylation.
This mutation, written as AG, replaces the nucleotide adenine with the nucleotide guanine at position in the MT-TL1 gene. The mutations that cause MELAS impair the ability of mitochondria to make proteins, use oxygen, and produce energy. They continue to investigate the effects of mitochondrial gene mutations in different tissues, particularly in the brain.
These genes provide instructions for making tRNA molecules, which are essential for protein production within mitochondria. This mutation, written as AG, replaces the nucleotide adenine with the nucleotide guanine at position in the MT-TK gene. It remains unclear how mutations in these genes lead to the muscle problems and neurological features of MERRF. The MT-ATP6 gene provides instructions for making a protein that is essential for normal mitochondrial function.
This protein forms one part subunit of an enzyme called ATP synthase. This enzyme, which is also known as complex V, is responsible for the last step of oxidative phosphorylation, in which a molecule called adenosine diphosphate ADP is converted to ATP.
It is unclear how this disruption in mitochondrial energy production leads to muscle weakness, vision loss, and the other specific features of NARP. Mutations in mitochondrial DNA are associated with nonsyndromic hearing loss, which is loss of hearing that is not associated with other signs and symptoms. This molecule helps assemble protein building blocks known as amino acids into functioning proteins that carry out oxidative phosphorylation within mitochondria.
Mutations in this gene increase the risk of hearing loss, particularly in people who take prescription antibiotic medications called aminoglycosides. These antibiotics are typically used to treat life-threatening and chronic bacterial infections such as tuberculosis.
Aminoglycosides kill bacteria by binding to their ribosomal RNA and disrupting the bacteria's ability to make proteins. The antibiotic easily binds to the abnormal 12S RNA, which impairs the ability of mitochondria to produce proteins needed for oxidative phosphorylation. Researchers believe that this unintended effect of aminoglycosides may reduce the amount of ATP produced in mitochondria, increase the production of harmful byproducts, and eventually cause the cell to self-destruct undergo apoptosis.
0コメント